335 related articles for article (PubMed ID: 16299790)
41. Patients with locally advanced esophageal carcinoma nonresponder to radiochemotherapy: who will benefit from surgery?
Piessen G; Briez N; Triboulet JP; Mariette C
Ann Surg Oncol; 2007 Jul; 14(7):2036-44. PubMed ID: 17453293
[TBL] [Abstract][Full Text] [Related]
42. Video-assisted laparoscopic resection of the esophagus for carcinoma after neoadjuvant therapy.
Aujesky R; Neoral C; Kral V; Bohanes T; Vrba R; Vomackova K
Hepatogastroenterology; 2009; 56(93):1035-8. PubMed ID: 19760936
[TBL] [Abstract][Full Text] [Related]
43. [Should adjuvant or neoadjuvant treatment be administered in esophageal cancer?].
Bedenne L
Ann Chir; 1997; 51(6):605-10. PubMed ID: 9406457
[TBL] [Abstract][Full Text] [Related]
44. Does neoadjuvant chemotherapy improve survival in patients with resectable thoracic oesophageal cancer?
Raja SG; Salhiyyah K; Nagarajan K
Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):661-4. PubMed ID: 17670718
[TBL] [Abstract][Full Text] [Related]
45. Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.
Abbrederis K; Bassermann F; Schuhmacher C; Voelter V; Busch R; Roethling N; Sendler A; Siewert JR; Peschel C; Lordick F
Ann Thorac Surg; 2006 Jul; 82(1):293-7. PubMed ID: 16798232
[TBL] [Abstract][Full Text] [Related]
46. [Review of combined chemoradiotherapy in the treatment of esophageal carcinoma].
Kocáková I; Soumarová R; Kocák I; Vyzula R
Cas Lek Cesk; 2003; 142 Suppl 1():22-5. PubMed ID: 12924045
[TBL] [Abstract][Full Text] [Related]
47. An appropriate esophagectomy for esophageal cancer: a lack of evidence and a growing disparity between Western and Eastern standards.
Nishimaki T
Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):231-3. PubMed ID: 16977290
[No Abstract] [Full Text] [Related]
48. A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia.
Liu JF; Jamieson GG; Wu TC; Zhu GJ; Drew PA
Ann Surg Oncol; 2009 May; 16(5):1397-402. PubMed ID: 19241108
[TBL] [Abstract][Full Text] [Related]
49. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
Ajani JA; Winter K; Okawara GS; Donohue JH; Pisters PW; Crane CH; Greskovich JF; Anne PR; Bradley JD; Willett C; Rich TA
J Clin Oncol; 2006 Aug; 24(24):3953-8. PubMed ID: 16921048
[TBL] [Abstract][Full Text] [Related]
50. Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer.
Roof KS; Coen J; Lynch TJ; Wright C; Fidias P; Willett CG; Choi NC
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1120-8. PubMed ID: 16730135
[TBL] [Abstract][Full Text] [Related]
51. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
[TBL] [Abstract][Full Text] [Related]
52. Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy.
Sperti C; Pasquali C; Pastorelli D; Ferronato A; Decet G; Pedrazzoli S
Acta Biomed; 2003; 74 Suppl 2():91-5. PubMed ID: 15055044
[TBL] [Abstract][Full Text] [Related]
53. Surgical resection with and without chemotherapy in oesophageal cancer.
Rath GK; Sharma DN; Shukla NK
Lancet; 2002 Oct; 360(9340):1174; author reply 1175. PubMed ID: 12387980
[No Abstract] [Full Text] [Related]
54. [Problematic results of a randomized study of neoadjuvant radiochemotherapy of operable esophageal carcinoma].
Fietkau R; Kundt G
Strahlenther Onkol; 2001 Jul; 177(7):372-3. PubMed ID: 11505624
[No Abstract] [Full Text] [Related]
55. [Efficacy of current adjuvant and neoadjuvant therapeutic concepts in gastric cancer?].
Kretzschmar A; Schlag PM
Zentralbl Chir; 2006 Apr; 131(2):121-5. PubMed ID: 16612778
[TBL] [Abstract][Full Text] [Related]
56. Neoadjuvant chemoradiotherapy in esophageal cancer: is it still the question?
Pereira B; Gourgou-Bourgade S; Azria D; Ychou M
J Clin Oncol; 2008 Nov; 26(31):5133-4; author reply 5134. PubMed ID: 18838699
[No Abstract] [Full Text] [Related]
57. Multimodality therapy of local regional esophageal cancer.
Kelsen DP
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S6-10. PubMed ID: 16399422
[TBL] [Abstract][Full Text] [Related]
58. [Adenocarcinoma of the Barrett esophagus. Apropos of 44 resected cases].
Lozac'h P; Topart P; Volant A
J Chir (Paris); 1997 Nov; 134(5-6):218-26. PubMed ID: 9772976
[No Abstract] [Full Text] [Related]
59. Neoadjuvant therapy of esophageal cancer.
Kelsen D
Can J Surg; 1989 Nov; 32(6):410-4. PubMed ID: 2479457
[TBL] [Abstract][Full Text] [Related]
60. Adjuvant chemoradiotherapy in gastric cancer and carcinoma of the oesophago-gastric junction.
Stahl M
Onkologie; 2004 Feb; 27(1):33-6. PubMed ID: 15007246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
